Your browser doesn't support javascript.
Intravenous Immunoglobulin for the Treatment of COVID-19: A Promising Tool.
Tzilas, Vasilios; Manali, Effrosyni; Papiris, Spyridon; Bouros, Demosthenes.
  • Tzilas V; First Academic Department of Pneumonology, Interstitial Lung Diseases Unit, Hospital for Diseases of the Chest, "Sotiria," Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Manali E; Athens Medical Center, Athens, Greece.
  • Papiris S; Second Pulmonary Medicine Department, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Bouros D; Second Pulmonary Medicine Department, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Respiration ; 99(12): 1087-1089, 2020.
Article in English | MEDLINE | ID: covidwho-1575797
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulins, Intravenous / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Respiration Year: 2020 Document Type: Article Affiliation country: 000512727

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulins, Intravenous / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Respiration Year: 2020 Document Type: Article Affiliation country: 000512727